MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Europe
*Europe: Regions
*Western Europe
Ireland
*Industry: Ireland
Pfizer Inc. (NYSE: PFE)
Finance & Acquisition: Pfizer
Metsera, Inc. (MTSR)
Finance & Acquisitions: Metsera
Parents
Metsera, Inc. (MTSR)
Children
2024: Metsera came out of stealth mode with $290 million in seed and Series A financing. ARCH and Population Health Partners, led the round with F-Prime Capital, GV, Mubadala Capital, Newpath Partners, and SoftBank Vision Fund 2 were also part of the financing.
2024: Population Health Partners alongside Arch Venture Partners, launched Metsera with the help of several other investors such as F-Prime Capital, GV, Mubadala Capital, Newpath Partners and SoftBank Vision Fund 2, alongside other undisclosed investors.
2024: With $290M in hand, newly emerged biotech Metsera thinks customizable combos are the future of obesity treatments
2025: Novo Nordisk Kicks Off Bloody Battle With Pfizer, Bidding $6.5 Billion On Metsera
2025: Obesity drug developer Metsera sets terms for $275M IPO_ seekingalpha.com
2025: Pfizer to Acquire Metsera and its Next-Generation Obesity Portfolio
2025: Pfizer to acquire obesity-focused Metsera in $4.9B deal
Zihipp
Jumps
Key People: Metsera
Organization & Developments: Metsera